Keyphrases
Molecular Docking
100%
Antibacterial Activity
45%
Antibacterial Agents
41%
Ferulic Acid
39%
Cyclooxygenase-2
37%
Hibiscus Sabdariffa
36%
Flavonoids
36%
Pinostrobin
33%
Methicillin-resistant Staphylococcus Aureus
30%
Cyclooxygenase-1 (COX-1)
30%
Escherichia Coli
24%
Antiplatelet
24%
2 Receptor
24%
P-coumaric Acid
23%
Boesenbergia Pandurata
23%
Roxb
23%
DNA Gyrase
20%
Antiplatelet Activity
18%
Chick Embryo Chorioallantoic Membrane
18%
Ferulic Acid Derivatives
18%
Luteolin Derivatives
18%
PBP2a
18%
Clinical Chemistry
18%
Cheminformatics
18%
Gossypol
18%
Drug Design
18%
Pharmaceutical Chemistry
18%
Derivative-based
18%
Antitumor Activity
18%
Vanillin
18%
ADMET Prediction
18%
Angiogenesis
18%
Chick Chorioallantoic Membrane Assay
18%
Multidrug Resistance
18%
Microencapsulation
18%
5-O-benzoylpinostrobin
18%
Activity Evaluation
18%
β-lactamase
18%
Microcapsules
18%
Vascular Endothelial Growth Factor
18%
Alginate Dialdehyde
18%
Lactobacillus Plantarum
18%
Physical Properties
18%
In Silico Analysis
18%
Roselle
18%
MCF-7 Cancer Cell Line
18%
P2Y12 Receptor
18%
In Vitro Anticancer Study
18%
Docking Time
18%
Time Evaluation
18%
Pharmacology, Toxicology and Pharmaceutical Science
Antiinfective Agent
46%
Antibacterial Activity
44%
Ferulic Acid
39%
Cyclooxygenase 2
36%
Hibiscus sabdariffa
36%
Flavonoid
36%
Escherichia coli
27%
Methicillin-Resistant Staphylococcus Aureus
27%
Cyclooxygenase 1
24%
Receptor
23%
Drug Development
21%
Absorption-Distribution-Metabolism-Excretion Toxicity
21%
DNA Topoisomerase (ATP Hydrolysing)
20%
Anticoagulant Agent
20%
Extended Spectrum Beta Lactamase
19%
Antitumor Activity
18%
Gelatin
18%
Anti-Inflammatory Drug
18%
Lactobacillus plantarum
18%
Pharmaceutical Chemistry
18%
Luteolin
18%
Breast Cancer
18%
Penicillinase
18%
Gossypetin
18%
Vanillin
18%
Chick
18%
Vasculotropin
18%
Cyclooxygenase 1 Inhibitor
18%
Multidrug Resistance
18%
Purinergic P2Y12 Receptor
18%
Benzoxazinone Derivative
18%
Acetylsalicylic Acid
18%
Antiplatelet
18%
Antithrombocytic Agent
15%
Mefenamic Acid
13%
Microparticle
13%
Hydroxycarbamide
13%
Breast Carcinoma
13%
Binding Site
13%
Alginic Acid
13%
Benzoxazine Derivative
12%
Recurrent Disease
12%
Atherosclerosis
12%
IC50
9%
Non-Steroidal Anti-Inflammatory Drug
9%
Microsphere
9%
Pharmacokinetics
8%
Side Effect
7%
Vanillin Derivative
7%
Prostacyclin
7%